162 related articles for article (PubMed ID: 37410587)
1. Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15.
Cai A; Zheng C; Qiu J; Fonarow GC; Lip GYH; Feng Y; Wang Z
Eur J Prev Cardiol; 2023 Sep; 30(13):1391-1400. PubMed ID: 37410587
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015.
Hao G; Wang X; Chen Z; Zhang L; Zhang Y; Wei B; Zheng C; Kang Y; Jiang L; Zhu Z; Zhang J; Wang Z; Gao R;
Eur J Heart Fail; 2019 Nov; 21(11):1329-1337. PubMed ID: 31746111
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community.
Xanthakis V; Enserro DM; Larson MG; Wollert KC; Januzzi JL; Levy D; Aragam J; Benjamin EJ; Cheng S; Wang TJ; Mitchell GF; Vasan RS
JACC Heart Fail; 2016 Oct; 4(10):808-815. PubMed ID: 27395350
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).
Lu J; Lu Y; Wang X; Li X; Linderman GC; Wu C; Cheng X; Mu L; Zhang H; Liu J; Su M; Zhao H; Spatz ES; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
Lancet; 2017 Dec; 390(10112):2549-2558. PubMed ID: 29102084
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis.
Wang H; Chai K; Du M; Wang S; Cai JP; Li Y; Zeng P; Zhu W; Zhan S; Yang J
Circ Heart Fail; 2021 Oct; 14(10):e008406. PubMed ID: 34455858
[TBL] [Abstract][Full Text] [Related]
6. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of heart failure stages among Chinese community populations: insight from a nationwide population-based study.
Zheng C; Cai A; Wang X; Qiu J; Song Q; Gu R; Cao X; Tian Y; Hu Z; Fonarow GC; Lip GYH; Wang Z; Feng Y
Lancet Reg Health West Pac; 2024 May; 46():101072. PubMed ID: 38706523
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of American Heart Association Heart Failure Stages in Black and White Young and Middle-Aged Adults: The CARDIA Study.
Gidding SS; Lloyd-Jones D; Lima J; Ambale-Venkatesh B; Shah SJ; Shah R; Lewis CE; Jacobs DR; Allen NB
Circ Heart Fail; 2019 Sep; 12(9):e005730. PubMed ID: 31505940
[TBL] [Abstract][Full Text] [Related]
9. The Prevalence of Stages of Heart Failure in Primary Care: A Population-Based Study.
Jorge AL; Rosa ML; Martins WA; Correia DM; Fernandes LC; Costa JA; Moscavitch SD; Jorge BA; Mesquita ET
J Card Fail; 2016 Feb; 22(2):153-7. PubMed ID: 26547013
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community.
Ammar KA; Jacobsen SJ; Mahoney DW; Kors JA; Redfield MM; Burnett JC; Rodeheffer RJ
Circulation; 2007 Mar; 115(12):1563-70. PubMed ID: 17353436
[TBL] [Abstract][Full Text] [Related]
11. Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010.
Kovell LC; Juraschek SP; Russell SD
PLoS One; 2015; 10(7):e0132228. PubMed ID: 26171960
[TBL] [Abstract][Full Text] [Related]
12. Burden of heart failure in Flemish general practices: a registry-based study in the Intego database.
Smeets M; Vaes B; Mamouris P; Van Den Akker M; Van Pottelbergh G; Goderis G; Janssens S; Aertgeerts B; Henrard S
BMJ Open; 2019 Jan; 9(1):e022972. PubMed ID: 30617099
[TBL] [Abstract][Full Text] [Related]
13. Trends in the Prevalence of Self-reported Heart Failure by Race/Ethnicity and Age From 2001 to 2016.
Rethy L; Petito LC; Vu THT; Kershaw K; Mehta R; Shah NS; Carnethon MR; Yancy CW; Lloyd-Jones DM; Khan SS
JAMA Cardiol; 2020 Dec; 5(12):1425-1429. PubMed ID: 32876652
[TBL] [Abstract][Full Text] [Related]
14. Burden of hypertension in China: A nationally representative survey of 174,621 adults.
Li Y; Yang L; Wang L; Zhang M; Huang Z; Deng Q; Zhou M; Chen Z; Wang L
Int J Cardiol; 2017 Jan; 227():516-523. PubMed ID: 27856040
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in the Associations of Traditional Risk Factors and Incident Heart Failure Hospitalization: A Prospective Cohort Study of 102 278 Chinese General Adults.
Qiu W; Cai A; Nie Z; Wang J; Ou Y; Feng Y
J Am Heart Assoc; 2024 May; 13(10):e033777. PubMed ID: 38726897
[TBL] [Abstract][Full Text] [Related]
16. Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
Kaneko H; Yano Y; Itoh H; Morita K; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Node K; Carey RM; Lima JAC; Oparil S; Yasunaga H; Komuro I
Circulation; 2021 Jun; 143(23):2244-2253. PubMed ID: 33886370
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study.
Abhayaratna WP; Smith WT; Becker NG; Marwick TH; Jeffery IM; McGill DA
Med J Aust; 2006 Feb; 184(4):151-4. PubMed ID: 16489896
[TBL] [Abstract][Full Text] [Related]
18. Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled Community Cohort.
Mohebi R; Wang D; Lau ES; Parekh JK; Allen N; Psaty BM; Benjamin EJ; Levy D; Wang TJ; Shah SJ; Gottdiener JS; Januzzi JL; Ho JE
J Am Coll Cardiol; 2023 Jun; 81(23):2231-2242. PubMed ID: 37286252
[TBL] [Abstract][Full Text] [Related]
19. Targets and management of hypertension in heart failure: focusing on the stages of heart failure.
Miao H; Zou C; Yang S; Chia YC; Van Huynh M; Sogunuru GP; Tay JC; Wang TD; Kario K; Zhang Y
J Clin Hypertens (Greenwich); 2022 Sep; 24(9):1218-1225. PubMed ID: 36196463
[TBL] [Abstract][Full Text] [Related]
20. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
